FDA Adverse Event Injury Summary report: N

ENDURANT II

MDR report key: 3840800 · Received May 30, 2014

Report

Report Number
2953200-2014-01080
Event Type
Injury
Date Received
May 30, 2014
Date of Event
May 6, 2014
Report Date
May 6, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

AN ENDURANT STENT GRAFT SYSTEM WAS INSERTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 46.1MM ABDOMINAL AORTIC ANEURYSM. VESSEL MORPHOLOGY WAS REPORTED AS THE DIAMETER OF THE PROXIMAL NECK IS 21.1MM AND 23.2MM AT THE DISTAL END. THE PROXIMAL NECK LENGTH IS 10MM. THE INFRARENAL NECK ANGLE IS 42.5 DEGREES. THE ACCESS DIAMETER AT THE RIGHT FEMORAL IS 7.1MM. THE ACCESS DIAMETER AT THE LEFT FEMORAL IS 6.2MM IT WAS REPORTED THAT DURING THE INDEX PROCEDURE AND WHILE ATTEMPTING TO PASS THE DELIVERY SYSTEM, EXCESSIVE CALCIUM DEPOSITS RESTRICTED ACCESS. THE PHYSICIAN DILATED THE RIGHT FEMORAL ARTERY WITH ANOTHER MANUFACTURER¿S DEVICE AND A BALLOON ANGIOPLASTY WAS ALSO USED TO IMPROVE PASSAGE. THE PHYSICIAN NOTED THAT THE ACCESS SITE WAS TOO SMALL AND DECIDED TO ABORT THE PROCEDURE AND CLOSE THE ACCESS SITE. POST OP DAY ONE, IT WAS REPORTED THAT THE PATIENT WAS FOUND TO HAVE COLD FEET. THE CAUSE OF THE COLD FEET IS UNKNOWN. THE PHYSICIAN DECIDED TO INTERVENE THE PATIENT BY PERFORMING A BILATERAL FEMORAL ENDART¿S AND A DISTAL PERIPHERAL INTERVENTION PROCEDURE. THE INTERVENTION WAS COMPLETED SUCCESSFULLY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS DOING FINE. A REVIEW OF RETURNED PRE-IMPLANT FILMS CONFIRMED THAT THE ACCESS VESSELS WERE SMALL IN CALIBER AND VERY CALCIFIED. IMAGES DURING IMPLANT WERE NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
318455 ENDURANT II SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V01140875

Patients

Seq Age Sex Outcome Treatment
1 00066 YR Required Intervention